Spots Global Cancer Trial Database for Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes
Official Title: Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes
Study ID: NCT02198092
Interventions
Study Description
Brief Summary: This is an observational, case-control study evaluating the quantitative level of Septin9 in plasma pre- and post-colectomy in hereditary colorectal cancer (CRC) syndrome patients (Familial Adenomatous Polyposis (FAP), Lynch syndrome (also known as HNPCC), and Multiple Adenomatous Polyposis (MAP, also known as MYK/MYH) cases) and genetically related FAP-family members as controls and references.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact Details
Name: Bryson Katona, MD
Affiliation: University of Pennsylvania
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
